Abstract
Heterocycles are the backbone of modern medical chemistry and drug development. The derivatization of “an olefin” inside aromatic rings represents an ideal approach to access functionalized saturated heterocycles from abundant aromatic building blocks. Here, we report an operationally simple, efficient, and practical method to selectively access hydrosilylated and reduced N-heterocycles from bicyclic aromatics via a key diradical intermediate. This approach is expected to facilitate complex heterocycle functionalizations that enable access to novel medicinally relevant scaffolds.
Heterocycles form the backbone of modern pharmaceuticals. Saturated heterocycles, in particular, represent important building blocks in the practice of medicinal chemistry.1-4 Despite their significance, the synthesis of saturated heterocycles, especially those having multiple substituents that are distal to a heteroatom, represents a formidable challenge.5 On the other hand, unsaturated heterocycles (e.g., heteroaromatics) are some of the most commercially abundant building blocks. Additionally, the πelectrons in the heteroaromatics are versatile functional handles for selective functionalizations.5-23 Regiocontrolled reduction of heteroarenes 1 to their saturated or semisaturated congeners 2 represents an attractive approach to access a diverse array of heterocyclic moieties (Figure 1A). Toward this end, the classic Birch reduction remains the state-of-art method to reduce (hetero)arenes. These techniques convert aromatics into radical anion intermediate 4, which is then protonated to afford reduced product 5 (Figure 1B).24-35 In recent years, other dearomatization strategies have also been reported.36-41 However, most of these methods are limited by substrate scope or harsh conditions. Developing mild alternative strategies capable of breaking the strong aromaticity in Lewis basic heteroaryls and with regioselective control remains an outstanding challenge. Inspired by the elegant reports of photoinduced [4+2] cycloaddition between heterocycles and olefins42-50 or triazolinediones,51-54 we envisaged that photo-excited-state intermediates such as 7 might be leveraged to provide regioselective hydrosilylated products 8 and reduced products 9 from abundant feedstocks in a controlled manner (Figure 1C). The dearomative hydrosilylation of heterocycles, in particular, might provide unique opportunities to access novel medicinally relevant scaffolds in medicinal chemistry settings. Heteroarylsilane derivatives, such as 8, potentially offer improved lipophilicity, stability, or pharmacokinetic properties.55-58 Moreover, the resulting allylsilane synthon would supply a synthetic handle for subsequent functionalization,59,60 enabling library synthesis of multiple-substituted saturated heterocycles featuring a higher fraction of sp3 carbon atoms (Fsp3)61,62 (Figure 1A).
Figure 1.
Regioselective saturation of bicyclic heterocycles. (A) Increasing aromatics saturation provides three-dimensional chemical space to escape from flatland; (B) classic Birch reduction breaks aromatics through radical anion intermediates; (C) proposed diradical synthon to access dearomatized hydrosilylation and reduction products from heterocycles.
Our dearomatization exploration commenced with the hypothesis that the photoexcited quinolinium intermediate might be reduced by a hydride reductant,42-54 such as silane reagents,63-69 to enable direct addition and reduction of the heteroarenes. During the solvent investigation, formation of an intriguing hydrosilylated product 11 was observed and subsequently optimized (Table 1, entry 1).70 The dearomatized allylic silane 11 was found to be sensitive to acidic conditions. However, the protic solvent hexafluoroisopropanol (HFIP) provided an optimal balance between promoting the addition and efficiently preserving product (compare entries 1 and 2 and vide infra).61,62 Other solvents led to lower yields or no product formation (entries 4–6). A series of photosensitizers were also investigated for this reaction, and only a small amount of 12 was observed (see Supporting Information for photosensitizer investigation). It is noteworthy that strict oxygen removal is not required for this reaction, with a product yield of 50% being observed when the reaction is conducted in the presence of air. The [2+2] photocycloaddition of allylic silane 11 was observed when prolonging the reaction time to 18 h (see SI-12, Supporting Information).
Table 1.
Saturation and Hydrosilylation Optimization of Quinolines
![]() | |||
---|---|---|---|
entry | deviation from above | yield of 11 |
12 (%)a |
Hydrosilylation: | |||
1 | none | 53 | <5 |
2 | TFA (2.0 equiv) as additive | 26 | 30 |
3 | Et3SiH (2.0 equiv) | 42 | 0 |
4 | CF3CH2OH instead of HFIP | 33 | <5 |
5 | iPrOH, CH2Cl2, THF, DMF instead of HFIP | 0 | 0 |
6 | HFIP (0.2 M) | 46 | <5 |
Reduction: | |||
7 | none | 0 | 75 |
8 | no TFA or UV irridiation | 0 | 0 |
9 | AcOH, MsOH, Et2O.BF3 instead of TFA | 0 | 0 |
10 | PhSiH3 or (EtO)3SiH instead of Et3SiH | 0 | 0 |
11 | hν 254 nm instead of 300 nm | 0 | 34 |
12 | hν 365 nm instead of 300 nm | 0 | 37 |
Yield determined by NMR analysis with CH2Br2 as an internal standard; quartz tubes were used for 254 nm reactions, and Pyrex tubes were used for 300 and 365 nm reactions. HFIP, hexafluoro-2-propanol. See the Supporting Information for experimental details.
Since the desilylated compound 12 is also of high synthetic utility, we intended to develop a one-step procedure to access 12 via in situ protonic desilylation of 11. After extensive optimization, the combination of trifluoroacetic acid (TFA) and triethylsilane under 300 nm photoirradiation led to the formation of the reduced product 12 in 75% yield (Table 1, entry 7; see the Supporting Information for other conditions and details). Both TFA and triethylsilane were found to be crucial for this reduction, and modifying the conditions to employ alternative acidic additives or reductants was detrimental (entries 8–10). Various wavelengths were also investigated, and 300 nm was identified as the optimal wavelength for the reduction of quinoline substrate 10 (entries 11–12).
To evaluate the substrate scopes for both the reactivities, the robustness of the reduction and hydrosilylation reactions was demonstrated through the preparation of over 50 dearomatized products from commercial heterocycles (Figure 2). The investigation started with 1,2-hydrosilyation of isoquinoline (Figure 2A), where various silane reagents were explored in this reaction, yet only trialkylsilane reagents could provide a noticeable amount of the hydrosilylated products (13–20). The bulky silane reagents, such as tri-isopropylsilane (16) or dimethyl-tert-butylsilane (20), led to lower yields, presumably due to steric hindrance. Other silanes often afford the reduced product 54, or a large amount of starting material remains (see the Supporting Information for results of other silanes). A wide range of quinolines (21–30) and isoquinolines (31–36) were studied using triethylsilane as the reductant. The alkyl groups (11, 28, 29) and cyano (24), ester (25), fluoro (30), chloro (27), and even vinyl (22) groups were well tolerated. For quinolines and isoquinolines, the C6- and C7-silylated products are the major regioisomers, respectively. For the isoquinolines (33–36) with an electron-withdrawing group at the C3-position, a mixture of silylated products (C7 and C6) was isolated. Furthermore, this reaction could extend to other heterocycles (see the Supporting Information), such as quinazoline (37). This reaction was also scalable and provided comparable yields on a 10 mmol scale (11, 13).
Figure 2.
Substrate scope of hydrosilylation and reduction of heterocycles. Products are racemic mixtures, unless annotated. (A) Hydrosilylation; heteroaromatics (1.0 equiv), triethyl silane (3.0 equiv) in HFIP (0.1 M) were stirred under UV (300 nm) irradiation for 12 h; a10 mmol scale; bunder UV 254 nm; cTFA (1.0 equiv) as additive; dTFA (1.5 equiv) as additive. (B) Reduction; heteroaromatics (1.0 equiv), TFA (2.0 equiv), triethyl silane (2.2 equiv) in MeCN (0.2 M) were stirred under UV (300 nm) irradiation for 12 h; e20 mmol scale; funder UV 365 nm; g5 mmol scale; hTFA (1.0 equiv), PhMe2SiH (3.0 equiv), MeCN (0.2 M), UV 300 nm; iTFA (1.0 equiv), Et3SiH (3.0 equiv), HFIP (0.1 M), UV 300 nm; jTFA (1.0 equiv), PhMe2SiH (3.0 equiv), HFIP (0.1 M), UV 300 nm; kPhMe2SiH (3.0 equiv), HFIP (0.1 M), UV 300 nm. See the Supporting Information for experimental details.
The substrate scope exploration of the reduction was initially evaluated on various quinolines (Figure 2B). Besides 5-substituted quinolines, other substitution patterns (38–53) were also found to be compatible in this reduction. Bromo (39, 43), primary benzylic alcohol (40, 50), ester (41, 44), cyano (42), methyl ether (45), chloro (47, 52), and boron pinacol ester (49) were all tolerated. Similarly, isoquinolines (54–56) were smoothly reduced under the standard conditions. The structures of compounds 40, 43, and 47 were unambiguously assigned by single-crystal X-ray analysis. The robustness of this operationally simple reaction was evaluated on multiple substrates by running the reduction at 5 to 20 mmol scales. The chemoselectivity of this transformation and applicability to medicinal-chemistry-relevant molecules were showcased by the successful reduction of deoxy-cinchonine (57) and fenazaquin (58).
The synthetic applicability of this dearomatization strategy was further showcased by derivatization of 11 and 12 to various saturated or partially saturated compounds, which are challenging to access otherwise (Figure 3A). For example, silylated compound 11 could undergo tetra-n-butylammonium fluoride (TBAF)-mediated allylic additions with aldehydes (59), benzyl bromides (60), propargyl bromides (61), or proton sources (12) to access C8-substituted dihydroquinoline products. Under DDQ oxidation conditions, the C6-silylated quinoline (62) was obtained in a high yield. Besides the intrinsic allyl silane reactivity, the remaining olefin moiety after dearomatization represents another versatile functional group for downstream derivatization. For example, Pd/C-catalyzed hydrogenation (65), [2+2]-photocycloaddition with dimethyl malonate (64), and hydroboration–oxidation (63) each produced the corresponding products in useful yields. In parallel, the partially reduced product 12 successfully underwent dihydroxylation (66), isomerization (67), N-oxide formation (68), addition into ketone (69), allylation (70), and reduction (71).
Figure 3.
Derivatization and synthetic application of dearomatized products. (A) Downstream derivatization of hydrosilylated compound 12 and reduced product 11; (B) synthetic application to access ORL1 antagonist 75; see the Supporting Information for experimental details.
This dearomative reduction method also enables more straightforward retrosynthetic disconnections for bioactive heterocycles by avoiding multistep and de novo syntheses of fused heterocycles. Cyclohexyl-fused pyridine 75 was developed as an opioid receptor-like 1 (ORL1) antagonist and was previously synthesized in 13 steps through de novo synthesis of the cyclohexyl ring (Figure 3B).71 Using the current method, we could simply access and subsequently employ quinoline reduced product 50 in a five-step sequence (alcohol protection with a triisopropylsilyl (TIPS) group, olefin isomerization, TBAF-assisted deprotection, installation of a p-toluenesulfonyl leaving group, Mukaiyama hydration, and SN2 substitution) to access the same antagonist with higher efficiency. Notably, this strategy enables one to utilize a commercially available substituted quinoline followed by rapid and divergent functionalization.
In order to understand the reaction mechanism, a series of deuterium labeling and control experiments were conducted (Figure 4A). Under the standard reduction conditions, reactions with the Et3Si-D (eq 1) and TFA-D (eq 2) indicated that the C5-proton (79) derives from the silane and the C8-proton is delivered by the acid (80/12). Deuteration of silylated product 11 with TFA-D afforded a similar 9:1 ratio of 80:12 (eq 3) to that observed in eq 2. This desilylation could also be thermally promoted at 60 °C (see Supporting Information). These results together suggested that the dearomative hydrosilylation is the initial step for the reduction. Despite the possibility of a radical mechanism, this reaction generated a noticeable amount of product in the presence of 4 equiv of TEMPO, albeit in lower yield, and no TEMPO adduct was detected by GC-MS or LC-MS (eq 4). In this context, TEMPO is less likely to act as a radical scavenger but instead might quench the photoexcited isoquinoline. We then turned our attention to understand the stereochemical outcome of this transformation. The deuterated-triethylsilane (eq 5) and C5-deuterated-quinoline (not shown) both resulted in a diastereomeric ratio of 9:1, favoring the syn hydrosilylation products (82 and 83). Crossover experiments with Et3Si-D and nBu3Si-H (eq 6) found no deuteron/proton scrambling between two different silanes. Based on experimental observations and mechanistic studies, we believe that the mechanism proceeds via a stepwise hydrogen atom transfer (HAT)/radical recombination mechanism (Figure 4B). The observed regioselectivities of the hydrosilylation are presumably due to the more electron-deficient radicals being photochemically generated at the 5-position of quinoline or 8-position of isoquinoline (intermediate B, Figure 4B). More detailed mechanistic studies, explanation for observed regioselectivity, and corresponding computational studies are ongoing and will be reported in due course.
Figure 4.
Mechanistic studies. (A) Mechanistic probe reactions: deuterium labeling experiments, TEMPO control experiment, hydrosilylation stereochemistry, and crossover experiment; (B) proposed mechanism.
In conclusion, we have developed a dearomatization method for the hydrosilylation and reduction of bicyclic heterocycles. As showcased in Figures 2 and 3, this operationally simple method enables rapid preparation of a variety of synthetically challenging saturated heterocycles in a chemoselective manner. In addition, the mechanistic studies demonstrate a stepwise HAT/radical recombination mechanism. We expect this method to have a substantial impact within the area of drug discovery through the combined derivatization and application of unique diradical synthons to access complex saturated heterocyclic building blocks.
Supplementary Material
ACKNOWLEDGMENTS
We thank Feng Lin (UTSW) for assistance with NMR spectroscopy; Hamid Baniasadi (UTSW) for HRMS; and Vincent Lynch (UT-Austin) for X-ray crystallographic analysis. We thank the Chen, Tambar, Ready, DeBrabander, Smith, and Falck groups (UT Southwestern) for generous access to equipment and helpful discussions. We are grateful to Bryan Matsuura, James Roane, and Xiao Wang (Merck) for feedback on this manuscript. We thank Robert Martin and Prof. Osvaldo Gutierrez (TAMU) for helpful discussions about the mechanism.
Funding
Financial support for this work was provided by National Institutes of Health (R01GM141088), the American Chemistry Society Petroleum Research Fund (62223-DNI1), Welch Foundation (I-2010–20190330), and UT Southwestern Eugene McDermott Scholarship (to T.Q.).
Footnotes
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.2c11664.
Detailed experimental procedures and characterization data for all compounds (PDF)
Accession Codes
CCDC 2201589–2201591, 2201593, and 2223773 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/ data_request/cif, or by emailing data_request@ccdc.cam.ac. uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
The authors declare no competing financial interest.
Contributor Information
Chao Hu, Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Cuong Vo, Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Rohan R. Merchant, Department of Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States
Si-Jie Chen, Department of Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States.
Jonathan M. E. Hughes, Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
Byron K. Peters, Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
Tian Qin, Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
REFERENCES
- (1).Vitaku E; Smith DT; Njardarson JT Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem 2014, 57, 10257–10274. [DOI] [PubMed] [Google Scholar]
- (2).Taylor RD; MacCoss M; Lawson ADG Rings in Drugs. J. Med. Chem 2014, 57, 5845–5859. [DOI] [PubMed] [Google Scholar]
- (3).Baumann M; Baxendale IR An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J. Org. Chem 2013, 9, 2265–2319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).Gomtsyan A Heterocycles in drugs and drug discovery. Chem. Heterocycl. Compd 2012, 48, 7–10. [Google Scholar]
- (5).Eicher T; Hauptmann S; Speicher A the Chemistry of Heterocycles: Structures, Reactions, Synthesis, and Applications; John Wiley & Sons, 2013. [Google Scholar]
- (6).Zhou X-Y; Zhang M; Liu Z; He J-H; Wang X-C C3-Selective Trifluoromethylthiolation and Difluoromethylthiolation of Pyridines and Pyridine Drugs via Dihydropyridine Intermediates. J. Am. Chem. Soc 2022, 144, 14463–14470. [DOI] [PubMed] [Google Scholar]
- (7).Woo J; Christian AH; Burgess SA; Jiang Y; Mansoor UF; Levin MD Scaffold hopping by net photochemical carbon deletion of azaarenes. Science 2022, 376, 527–532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Nallagonda R; Musaev DG; Karimov RR Light-Promoted Dearomative Cross-Coupling of Heteroarenium Salts and Aryl Iodides via Nickel Catalysis. ACS Catal 2022, 12, 1818–1829. [Google Scholar]
- (9).Liu Z; He J-H; Zhang M; Shi Z-J; Tang H; Zhou X-Y; Tian J-J; Wang X-C Borane-Catalyzed C3-Alkylation of Pyridines with Imines, Aldehydes, or Ketones as Electrophiles. J. Am. Chem. Soc 2022, 144, 4810–4818. [DOI] [PubMed] [Google Scholar]
- (10).Jeong E; Heo J; Jin S; Kim D; Chang S KOtBu-Catalyzed 1,2-Silaboration of N-Heteroarenes to Access 2-Silylheterocycles: A Cooperative Model for the Regioselectivity. ACS Catal. 2022, 12, 4898–4905. [Google Scholar]
- (11).Ham WS; Choi H; Zhang J; Kim D; Chang S C2-Selective, Functional-Group-Divergent Amination of Pyrimidines by Enthalpy-Controlled Nucleophilic Functionalization. J. Am. Chem. Soc 2022, 144, 2885–2892. [DOI] [PubMed] [Google Scholar]
- (12).Zhang X; Nottingham KG; Patel C; Alegre-Requena JV; Levy JN; Paton RS; McNally A Phosphorus-mediated sp2-sp3 couplings for C-H fluoroalkylation of azines. Nature 2021, 594, 217–222. [DOI] [PubMed] [Google Scholar]
- (13).Kim JH; Constantin T; Simonetti M; Llaveria J; Sheikh NS; Leonori D A radical approach for the selective C-H borylation of azines. Nature 2021, 595, 677–683. [DOI] [PubMed] [Google Scholar]
- (14).Heusler A; Fliege J; Wagener T; Glorius F Substituted Dihydropyridine Synthesis by Dearomatization of Pyridines. Angew. Chem., Int. Ed 2021, 60, 13793–13797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Zhou M; Tsien J; Qin T Sulfur(IV)-Mediated Unsymmetrical Heterocycle Cross-Couplings. Angew. Chem., Int. Ed 2020, 59, 7372–7376. [DOI] [PubMed] [Google Scholar]
- (16).Nairoukh Z; Wollenburg M; Schlepphorst C; Bergander K; Glorius F The formation of all-cis-(multi)fluorinated piperidines by a dearomatization-hydrogenation process. Nat. Chem 2019, 11, 264–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).Proctor RS; Davis HJ; Phipps RJ Catalytic enantioselective Minisci-type addition to heteroarenes. Science 2018, 360, 419–422. [DOI] [PubMed] [Google Scholar]
- (18).Hilton MC; Zhang X; Boyle BT; Alegre-Requena JV; Paton RS; McNally A Heterobiaryl synthesis by contractive C-C coupling via P (V) intermediates. Science 2018, 362, 799–804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (19).Gribble MW; Guo S; Buchwald SL Asymmetric Cu-Catalyzed 1,4-Dearomatization of Pyridines and Pyridazines without Preactivation of the Heterocycle or Nucleophile. J. Am. Chem. Soc 2018, 140, 5057–5060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Murakami K; Yamada S; Kaneda T; Itami K C-H Functionalization of Azines. Chem. Rev 2017, 117, 9302–9332. [DOI] [PubMed] [Google Scholar]
- (21).Lutz JP; Chau ST; Doyle AG Nickel-catalyzed enantioselective arylation of pyridine. Chem. Sci 2016, 7, 4105–4109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).Gandhamsetty N; Park S; Chang S Selective Silylative Reduction of Pyridines Leading to Structurally Diverse Azacyclic Compounds with the Formation of sp3 C-Si Bonds. J. Am. Chem. Soc 2015, 137, 15176–15184. [DOI] [PubMed] [Google Scholar]
- (23).Gandhamsetty N; Joung S; Park S-W; Park S; Chang S Boron-Catalyzed Silylative Reduction of Quinolines: Selective sp3 C-Si Bond Formation. J. Am. Chem. Soc 2014, 136, 16780–16783. [DOI] [PubMed] [Google Scholar]
- (24).Burrows J; Kamo S; Koide K Scalable Birch reduction with lithium and ethylenediamine in tetrahydrofuran. Science 2021, 374, 741–746. [DOI] [PubMed] [Google Scholar]
- (25).Remers WA; Gibs GJ; Pidacks C; Weiss MJ Reduction of nitrogen heterocycles by lithium in liquid ammonia. III. Indoles and quinolines. J. Org. Chem 1971, 36, 279–284. [Google Scholar]
- (26).Birch AJ 117. Reduction by dissolving metals. Part I. J. Chem. Soc 1944, 430–436. [Google Scholar]
- (27).Hayashi K; Griffin J; Harper KC; Kawamata Y; Baran PS Chemoselective (Hetero)Arene Electroreduction Enabled by Rapid Alternating Polarity. J. Am. Chem. Soc 2022, 144, 5762–5768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Peters BK; Rodriguez KX; Reisberg SH; Beil SB; Hickey DP; Kawamata Y; Collins M; Starr J; Chen L; Udyavara S Scalable and safe synthetic organic electroreduction inspired by Li-ion battery chemistry. Science 2019, 363, 838–845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Birch AJ Electrolytic reduction in liquid ammonia. Nature 1946, 158, 60–60.20991745 [Google Scholar]
- (30).Dai W; Geib SJ; Curran DP 1,4-Hydroboration Reactions of Electron-Poor Aromatic Rings by N-Heterocyclic Carbene Boranes. J. Am. Chem. Soc 2020, 142, 6261–6267. [DOI] [PubMed] [Google Scholar]
- (31).Cole JP; Chen D-F; Kudisch M; Pearson RM; Lim CH; Miyake GM Organocatalyzed Birch reduction driven by visible light. J. Am. Chem. Soc 2020, 142, 13573–13581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).Chatterjee A; König B Birch-Type Photoreduction of Arenes and Heteroarenes by Sensitized Electron Transfer. Angew. Chem., Int. Ed 2019, 58, 14289–14294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (33).Yoshimi Y; Ishise A; Oda H; Moriguchi Y; Kanezaki H; Nakaya Y; Katsuno K; Itou T; Inagaki S; Morita T; Hatanaka M Hydroxide ion as electron source for photochemical Birch-type reduction and photodehalogenation. Tetrahedron Lett. 2008, 49, 3400–3404. [Google Scholar]
- (34).Yasuda M; Pac C; Sakurai H Photochemical reactions of aromatic compounds. 35. Photo-Birch reduction of arenes with sodium borohydride in the presence of dicyanobenzene. J. Org. Chem 1981, 46, 788–792. [Google Scholar]
- (35).Yonemitsu O; Cerutti P; Witkop B Photoreductions and photocyclizations of tryptophan. J. Am. Chem. Soc 1966, 88, 3941–3945. [DOI] [PubMed] [Google Scholar]
- (36).Cheng Y-Z; Feng Z; Zhang X; You S-L Visible-light induced dearomatization reactions. Chem. Soc. Rev 2022, 51, 2145–2170. [DOI] [PubMed] [Google Scholar]
- (37).Okumura M; Sarlah D Visible-light-induced dearomatizations. Eur. J. Org. Chem 2020, 2020, 1259–1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Wertjes WC; Southgate EH; Sarlah D Recent advances in chemical dearomatization of nonactivated arenes. Chem. Soc. Rev 2018, 47, 7996–8017. [DOI] [PubMed] [Google Scholar]
- (39).Roche SP; Porco JA Jr Dearomatization strategies in the synthesis of complex natural products. Angew. Chem., Int. Ed 2011, 50, 4068–4093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (40).Lopez Ortiz F; Iglesias MJ; Fernandez I; Andujar Sanchez CM; Ruiz Gómez G Nucleophilic dearomatizing (DNAr) reactions of aromatic C, H-systems. A mature paradigm in organic synthesis. Chem. Rev 2007, 107, 1580–1691. [DOI] [PubMed] [Google Scholar]
- (41).Pape AR; Kaliappan KP; Kündig EP Transition-metal-mediated dearomatization reactions. Chem. Rev 2000, 100, 2917–2940. [DOI] [PubMed] [Google Scholar]
- (42).Guo R; Adak S; Bellotti P; Gao X; Smith WW; Le SN; Ma J; Houk KN; Glorius F; Chen S; Brown MK Photochemical Dearomative Cycloadditions of Quinolines and Alkenes: Scope and Mechanism Studies. J. Am. Chem. Soc 2022, 144, 17680–17691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (43).Bellotti P; Rogge T; Paulus F; Laskar R; Rendel N; Ma J; Houk KN; Glorius F Visible-Light Photocatalyzed peri-(3 + 2) Cycloadditions of Quinolines. J. Am. Chem. Soc 2022, 144, 15662–15671. [DOI] [PubMed] [Google Scholar]
- (44).Ma J; Chen S; Bellotti P; Wagener T; Daniliuc C; Houk KN; Glorius F Facile access to fused 2D/3D rings via intermolecular cascade dearomative [2+ 2] cycloaddition/rearrangement reactions of quinolines with alkenes. Nat. Catal 2022, 5, 405–413. [Google Scholar]
- (45).Ji P; Davies CC; Gao F; Chen J; Meng X; Houk KN; Chen S; Wang W Selective skeletal editing of polycyclic arenes using organophotoredox dearomative functionalization. Nat. Commun 2022, 13, 4565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (46).Morofuji T; Nagai S; Chitose Y; Abe M; Kano N Protonation-Enhanced Reactivity of Triplet State in Dearomative Photocycloaddition of Quinolines to Olefins. Org. Lett 2021, 23, 6257–6261. [DOI] [PubMed] [Google Scholar]
- (47).Ma J; Chen S; Bellotti P; Guo R; Schäfer F; Heusler A; Zhang X; Daniliuc C; Brown MK; Houk KN; Glorius F Photochemical intermolecular dearomative cycloaddition of bicyclic azaarenes with alkenes. Science 2021, 371, 1338–1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (48).Leitch JA; Rogova T; Duarte F; Dixon DJ Dearomative Photocatalytic Construction of Bridged 1, 3-Diazepanes. Angew. Chem., Int. Ed 2020, 132, 4150–4159. [DOI] [PubMed] [Google Scholar]
- (49).Ma J; Strieth-Kalthoff F; Dalton T; Freitag M; Schwarz JL; Bergander K; Daniliuc C; Glorius F Direct dearomatization of pyridines via an energy-transfer-catalyzed intramolecular [4+ 2] cycloaddition. Chem. 2019, 5, 2854–2864. [Google Scholar]
- (50).Döpp D; Jung A Photocycloaddition of 2-Morpholinopro-penenitrile to 8-Acetylquinoline. Acta Chim. Slov 2009, 56, 664–668. [Google Scholar]
- (51).Siddiqi Z; Wertjes WC; Sarlah D Chemical equivalent of arene monooxygenases: dearomative synthesis of arene oxides and oxepines. J. Am. Chem. Soc 2020, 142, 10125–10131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (52).Tang C; Okumura M; Deng H; Sarlah D Palladium-Catalyzed Dearomative syn-1, 4-Oxyamination. Angew. Chem., Int. Ed 2019, 58, 15762–15766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (53).Southgate EH; Pospech J; Fu J; Holycross DR; Sarlah D Dearomative dihydroxylation with arenophiles. Nat. Chem 2016, 8, 922–928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (54).Okumura M; Nakamata Huynh SM; Pospech J; Sarlah D Arenophile-Mediated Dearomative Reduction. Angew. Chem., Int. Ed 2016, 128, 16142–16146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (55).Ramesh R; Reddy DS Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds. J. Med. Chem 2018, 61, 3779–3798. [DOI] [PubMed] [Google Scholar]
- (56).Hu Y Wang Y; Li F; Ma C; Wang J Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. Eur. J. Med. Chem 2017, 135, 70–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (57).Franz AK; Wilson SO Organosilicon Molecules with Medicinal Applications. J. Med. Chem 2013, 56, 388–405. [DOI] [PubMed] [Google Scholar]
- (58).Showell GA; Mills JS Chemistry challenges in lead optimization: silicon isosteres in drug discovery. Drug discovery today 2003, 8, 551–556. [DOI] [PubMed] [Google Scholar]
- (59).Chabaud L; James P; Landais Y Allylsilanes in organic synthesis- recent developments. Eur. J. Org. Chem 2004, 2004, 3173–3199. [Google Scholar]
- (60).Denmark SE; Fu J Catalytic enantioselective addition of allylic organometallic reagents to aldehydes and ketones. Chem. Rev 2003, 103, 2763–2794. [DOI] [PubMed] [Google Scholar]
- (61).Talele TT Opportunities for tapping into three-dimensional chemical space through a quaternary carbon. J. Med. Chem 2020, 63, 13291–13315. [DOI] [PubMed] [Google Scholar]
- (62).Lovering F; Bikker J; Humblet C Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem 2009, 52, 6752–6756. [DOI] [PubMed] [Google Scholar]
- (63).Walker JC; Klare HF; Oestreich M Cationic silicon Lewis acids in catalysis. Nat. Rev. Chem 2020, 4, 54–62. [Google Scholar]
- (64).Richter SC; Oestreich M Emerging Strategies for C-H Silylation. Trends in Chemistry 2020, 2, 13–27. [Google Scholar]
- (65).Asgari P; Hua Y; Bokka A; Thiamsiri C; Prasitwatcharakorn W; Karedath A; Chen X; Sardar S; Yum K; Leem G Catalytic hydrogen atom transfer from hydrosilanes to vinylarenes for hydrosilylation and polymerization. Nat. Catal 2019, 2, 164–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (66).Obligacion JV; Chirik PJ Earth-abundant transition metal catalysts for alkene hydrosilylation and hydroboration. Nat. Rev. Chem 2018, 2, 15–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (67).Smith AJ; Young A; Rohrbach S; O’Connor EF; Allison M; Wang HS; Poole DL; Tuttle T; Murphy JA Electron-Transfer and Hydride-Transfer Pathways in the Stoltz-Grubbs Reducing System (KOtBu/Et3SiH). Angew. Chem., Int. Ed 2017, 56, 13747–13751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (68).Park S; Chang S Catalytic Dearomatization of N-Heteroarenes with Silicon and Boron Compounds. Angew. Chem., Int. Ed 2017, 56, 7720–7738. [DOI] [PubMed] [Google Scholar]
- (69).Toutov AA; Liu W-B; Betz KN; Fedorov A; Stoltz BM; Grubbs RH Silylation of C-H bonds in aromatic heterocycles by an Earth-abundant metal catalyst. Nature 2015, 518, 80–84. [DOI] [PubMed] [Google Scholar]
- (70).Generally, a trace amount to no 1,4-hydrosilylation of dearomatized quinoline or isoquinoline product was observed (crude NMR analysis of 1,2- and 1,4-hydrosilylation in the SI). Noteworthy, out of all the substrates, we could isolate 1,4-silylation product in only one case, SI-8, in 4% yield on a 1 mmol scale.
- (71).Yoshizumi T; Takahashi H; Miyazoe H; Sugimoto Y; Tsujita T; Kato T; Ito H; Kawamoto H; Hirayama M; Ichikawa D et al. A novel class of cycloalkano [b] pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channel. J. Med. Chem 2008, 51, 4021–4029. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.